Search research articles
Contact Us
Filters
Showing results (101-110 of 123) with videos related to
Page
of 13
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 23, 2016
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial
Miriam Krischke, Georg Hempel, Swantje Völler, et al.
Cancer Chemotherapy and Pharmacology
|
June 18, 2003
Population pharmacokinetics of oral busulfan in children
Brunhild Schiltmeyer, Thomas Klingebiel, Matthias Schwab, et al.
BMC Geriatrics
|
January 20, 2017
Effect of training and structured medication review on medication appropriateness in nursing home residents and on cooperation between health care professionals: the InTherAKT study protocol
Angelika Mahlknecht, Nadja Nestler, Ulrike Bauer, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 28, 2022
<i>Hypericum perforatum</i> and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
Fakry F Mohamed, Darisuren Anhlan, Michael Schöfbänker, et al.
Cancer Chemotherapy and Pharmacology
|
January 15, 2013
Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years
Nina E Kontny, Gudrun Würthwein, Boos Joachim, et al.
European Journal of Clinical Pharmacology
|
December 17, 2009
Pharmacokinetics of linezolid in septic patients with and without extended dialysis
Stefanie Swoboda, Michael C Ober, Christoph Lichtenstern, et al.
BMC Pharmacology & Toxicology
|
March 8, 2019
Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
Johanna K Freundt, Gerrit Frommeyer, Tilmann Spieker, et al.
Planta Medica
|
March 25, 2024
Rationalising Optimal Dosing of Phytotherapeutics For Use In Children: Current Status - Potential Solutions - Actions Needed
Andreas Hensel, Rudolf Bauer, Michael Heinrich, et al.
Cancers
|
April 11, 2020
The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
Philipp Berning, Carolin Hennemann, Claudia Tulotta, et al.
Clinical Pharmacokinetics
|
September 17, 2020
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling
Pablo Zubiaur, Lisa A Kneller, Dolores Ochoa, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 123) with videos related to
Sort By:
Page
of 13
Cancer Chemotherapy and Pharmacology
|
October 23, 2016
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial
Miriam Krischke, Georg Hempel, Swantje Völler, et al.
Cancer Chemotherapy and Pharmacology
|
June 18, 2003
Population pharmacokinetics of oral busulfan in children
Brunhild Schiltmeyer, Thomas Klingebiel, Matthias Schwab, et al.
BMC Geriatrics
|
January 20, 2017
Effect of training and structured medication review on medication appropriateness in nursing home residents and on cooperation between health care professionals: the InTherAKT study protocol
Angelika Mahlknecht, Nadja Nestler, Ulrike Bauer, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 28, 2022
<i>Hypericum perforatum</i> and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
Fakry F Mohamed, Darisuren Anhlan, Michael Schöfbänker, et al.
Cancer Chemotherapy and Pharmacology
|
January 15, 2013
Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years
Nina E Kontny, Gudrun Würthwein, Boos Joachim, et al.
European Journal of Clinical Pharmacology
|
December 17, 2009
Pharmacokinetics of linezolid in septic patients with and without extended dialysis
Stefanie Swoboda, Michael C Ober, Christoph Lichtenstern, et al.
BMC Pharmacology & Toxicology
|
March 8, 2019
Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
Johanna K Freundt, Gerrit Frommeyer, Tilmann Spieker, et al.
Planta Medica
|
March 25, 2024
Rationalising Optimal Dosing of Phytotherapeutics For Use In Children: Current Status - Potential Solutions - Actions Needed
Andreas Hensel, Rudolf Bauer, Michael Heinrich, et al.
Cancers
|
April 11, 2020
The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
Philipp Berning, Carolin Hennemann, Claudia Tulotta, et al.
Clinical Pharmacokinetics
|
September 17, 2020
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling
Pablo Zubiaur, Lisa A Kneller, Dolores Ochoa, et al.
Page
of 13